Approval · Notice of Compliance 1673 · 1999
MIGRANAL: Notice of Compliance 1673
Issued November 4, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1673
- Date
- November 4, 1999
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions
- Therapeutic class
- 5-ht1 receptor agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIGRANAL | Not yet assigned | — |
Medicinal ingredients
- DIHYDROERGOTAMINE MESYLATE 4 MG per ML